As a 16-year CLL patient himself, Brad brings a personal perspective as Dr. Rogers explains

In this episode of the Patient Power podcast, Unraveling Cancer, patient host Brad

In this episode of the Patient Power podcast, Unraveling Cancer, patient host Michele Nadeem-Baker is joined by Thomas Kipps, MD, PhD, UC San Diego, for a conversation about the latest immune-based advances in chronic lymphocytic leukemia (CLL), including targeted therapies, CAR T-cell treatment, vaccines, and infection prevention. Learn how new research is improving outcomes and bringing hope for a future cure.

Patient advocate, Michele Nadeem Baker, hosts Boyu Hu, MD, Director of Lymphoma and Chronic Lymphocytic Leukemia at the Huntsman Cancer Institute at the University of Utah for a discussion on fixed duration treatment.

Physician assistant Jill Miller shares what CLL patients really need to know about fixed-duration treatment. Learn how to manage side effects, what to expect month by month, when treatment ends, and how to navigate the emotional transition from active therapy to surveillance.

In this episode of Patient Power’s podcast Unraveling Cancer, patient host

In this episode of the Patient Power podcast, Unraveling Cancer, patient host, Michele Nadeem-Baker is joined by Deborah Stephens, DO, UNC at Chapel Hill, for a conversation about choosing a treatment for CLL, when to consider a clinical trial and the pros and cons of fixed duration vs continuous therapy.

In this episode of the Patient Power podcast, Unraveling Cancer, patient host,

In this episode of the Patient Power podcast, Unraveling Cancer, patient host, Brad Adams is joined by Thomas Kipps, MD UC San Diego, for a conversation about why the move from chemotherapy to targeted treatments is a game changer for older CLL patients and those with co-morbidities.